Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis

Tuberculosis remains the biggest infectious threat to humanity with one-third of the population infected and 1.4 million deaths and 8.7 million new cases annually. Current tuberculosis therapy is lengthy and consists of multiple antimicrobials, which causes poor compliance and high treatment dropout...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bhattacharya, Debapriya, Dwivedi, Ved Prakash, Maiga, Mamoudou, Maiga, Mariama, Van Kaer, Luc, Bishai, William R., Das, Gobardhan
Format: Artigo
Idioma:Inglês
Publicat: American Society for Biochemistry and Molecular Biology 2014
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4047417/
https://ncbi.nlm.nih.gov/pubmed/24711459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M114.558098
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars